Therefore, dual GLP-1/glucagon co-agonists, such as survodutide [82], cotadutide [83] and pemvidutide [84] yield greater improvements in hepatic steatosis and fibrosis biomarkers than GLP-1 monotherapy, reflecting additive modulation of mitochondrial and inflammatory pathways
We carry a reaction kit on every visit (antihistamines, epinephrine, IV fluids), follow the same evidence-based protocols we were trained on in hospital settings, and our intake is built to flag anything that raises the risk before the line ever runs
Microglial activation and hypothalamic structural plasticity in HFD metabolic research [PMID: 39724960] Laboratory literature summary: Microglial activation and hypothalamic structural plasticity in HFD metabolic research models: insights from semaglutide and minocycline
[Crossref] [PubMed] Mollan SP, Tahrani AA, Sinclair AJ